No profile data available.
Natera, Inc. (NTRA) is a healthcare company in the DNA testing equipment industry, based in Austin, United States, with about 6,135 full-time employees.
It reported revenue of $2.31 billion for fiscal year 2025, up 35.7% from fiscal year 2024, and net income of -$208.16 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $752.75 million, up 37.7% from a year before. United States was its largest region in fiscal year 2025, with 98% of revenue. Its market capitalization was $57.76 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Natera reported $2.31 billion in revenue for fiscal year 2025, up 35.7% from $1.70 billion in fiscal year 2024. In Q2 2026 revenue was $752.75 million.
United States: 98% of revenue by region in fiscal year 2025, followed by Europe, Middle East, India, Africa (1%).
$57.76 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Guardant Health, Inc. (GH), Tempus AI, Inc. (TEM), Qiagen N.v. (QGEN), Caris Life Sciences, Inc. (CAI).